9:40am ET
Health and Healthcare
Why This New Dementia Study Is a Huge Hit
Acadia Pharmaceuticals shares rose sharply early Monday after the firm announced that its late-stage dementia study met its primary endpoint.
Chris Lange
Companies
/Healthcare
Acadia Pharmaceuticals Inc
$28.91
▼ $0.20 (−0.69%) today
Markets closed · 7:19pm ET
ACAD Coverage
Page 3 Chris Lange 12:05pm ET
Health and Healthcare
Is Acadia Pharma’s Schizophrenia Treatment Done For?
Acadia Pharmaceuticals shares dropped on Tuesday after the firm announced results from its late-stage study for the treatment of adult schizophrenia patients.
Chris Lange 12:15pm ET
Health and Healthcare
Acadia Pharma Slides Despite Positive Major Depressive Disorder Results
Acadia Pharmaceuticals shares dipped on Wednesday despite announcing positive top-line results from its Clarity mid-stage study in major depressive disorder (MDD).
Chris Lange 11:50am ET
Health and Healthcare
What the FDA Has to Say About Acadia Pharma’s Parkinson’s Treatment
Acadia Pharmaceuticals shares popped after the company announced that the FDA completed a postmarketing review and issued a clear statement reaffirming the positive benefit-risk profile of Nuplazid for patients with Parkinson’s disease…
Chris Lange 9:10am ET
Investing
Top Analyst Upgrades and Downgrades: AMD, Alcoa, AT&T, Darden, Micron, New Age Beverages, Nike, Novavax, Pier 1, Under Armour and More
The top analyst upgrades, downgrades and initiations seen on Friday include AMD, Alcoa, AT&T, Darden Restaurants, Micron Technology, New Age Beverages, Nike, Novavax, Pier 1 Imports and Under Armour.
10:55am ET
Health and Healthcare
Merrill Lynch Sees 4 Top Biotechs With Key Catalysts in 2018
With 2018 coming to a close in just a few months, Merrill Lynch is taking a close look at the biotech industry and what key catalysts to expect before 2019.
8:45am ET
Investing
Top Analyst Upgrades and Downgrades: Aetna, Analog Devices, Lowe’s, Merck, Pfizer, Plug Power, Qualcomm, Target and More
The top analyst upgrades, downgrades and initiations seen on Thursday include Aetna, Analog Devices, Lowe's, Merck, Pfizer, Plug Power, Qualcomm and Target.
4:04pm ET
Investing
Coty, e.l.f Beauty Sink into Thursday’s 52-Week Low Club
Ultra Petroleum, Coty, e.l.f. Beauty, and Acadia Pharmaceuticals all posted new 52-week lows Thursday.
11:55am ET
Investing
6 Stocks Defying the Bull Market With Multiple Analyst Downgrades and Price Target Cuts
24/7 Wall St. tracked six companies that saw three or more analyst downgrades or price target cuts on Thursday, August 9, 2018.
9:10am ET
Investing
Top Analyst Upgrades and Downgrades: Applied Materials, Extreme Networks, Mylan, NXP, Roku, Seagate, Yelp, Zynga and More
The top analyst upgrades, downgrades and other research calls from Thursday include Applied Materials, Extreme Networks, Mylan, NXP, Roku, Seagate, Yelp and Zynga.
9:00am ET
Investing
Top Analyst Upgrades and Downgrades: Broadcom, CBS, Etsy, Illumina, PulteGroup, SeaWorld, Wynn Resorts, Zillow and More
The top analyst upgrades, downgrades and other research calls from Tuesday include Broadcom, CBS, Etsy, Illumina, PulteGroup, SeaWorld, Wynn Resorts and Zillow.
4:04pm ET
Investing
Mannkind, Tesaro Can’t Escape Monday’s 52-Week Low Club
Mannkind, Tesaro, Acadia Pharmaceuticals, and Diebold Nixdorf all posted new 52-week lows Monday.
4:03pm ET
Investing
Coca-Cola, LendingClub Skid into Wednesday’s 52-Week Low Club
LendingClub, Coca-Cola, Acadia Pharmaceuticals, and Bristol-Myers Squibb all posted new 52-week lows Wednesday.
4:04pm ET
Investing
Acadia, Incyte Show the Way to Monday’s 52-Week Low Club
Acadia Pharmaceuticals, Veo, Sibanye Gold, and Incyte Pharmaceuticals all posted new 52-week lows Monday.
9:40am ET
Health and Healthcare
Analyst Has 4 Favorite Biotechnology Stocks to Buy Now
A new Merrill Lynch research report makes the case that four top biotech companies the firm covers have some powerful catalysts that could drive performance this year.
Lee Jackson